Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

ANTH 7.39 -0.16 (-2.12%)
price chart
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Price Target Update
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) stock has received a short term price target of $ 13 from 2 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $1.41.
Fall in love with these 3 Biotech stocks: Anthera Pharmaceuticals Inc ...  Wall Street Point
Fri Pre-Market Outlook: Gas Natural Inc. (EGAS), Anthera Pharmaceuticals ...  WallStreet Scope
Anthera Pharmaceuticals, Inc. Short Interest Update
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), A rise of 274,559 shares or 14.5% was seen in the short interest of Anthera Pharmaceuticals, Inc.. Even as the interest increased from 1,896,128 shares on July 31,2015 to 2,170,687 shares on August 14,2015, ...
Why Anthera Pharmaceuticals, Inc. Shares Are Soaring Higher
What: Shares in Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) jumped by 10% earlier today after the company announced after the bell yesterday that it would present updated data from its phase 2b study evaluating blisibimod as a treatment for lupus at an ...
Shares of Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Sees Large Outflow of Money
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) During the most recent session, the shares traded at 0.05 points or 0.71% higher at $7.09.
Zacks Short Term Rating on Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH)  American Trade Journal
Anthera Pharmaceuticals, Inc. Price Target Update
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH): The mean short term price target for Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) has been established at $13 per share. The higher price target estimate is at $14 and the lower price target estimate is ...
Shares of Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Drops by -23.64%
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) has lost 23.64% during the past week and dropped 34.88% in the last 4 weeks.
Morning Investor Watch: 500.com Limited (WBAI), Anthera Pharmaceuticals, Inc ...  WallStreet Scope
Short Interest Update on Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH)
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), A drop of 286,385 shares or 13.1% was seen in the short interest of Anthera Pharmaceuticals, Inc.. Even as the interest dropped from 2,182,513 shares on July 15,2015 to 1,896,128 shares on July 31,2015, the ...
Biotech Stocks Worth Chasing - Anthera Pharmaceuticals Inc (NASDAQ:ANTH ...  Wall Street Observer
Stocks News Update: Anthera Pharmaceuticals (ANTH), BGC Partners (BGCP ...  Techsonian (press release)
Biotech Stocks with Pessimistic Trend: Vital Therapies Inc (NASDAQ:VTL ...
The S&P 500 Biotech Index has nearly tripled in the past three years. The index had stalled and moved sideways for much of the past spring, leading some to wonder whether the rally was spent.
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) on Watch
[Benzinga] Anthera Pharmaceuticals Inc (NASDAQ:ANTH)(TREND ANALYSIS) announced that it has completed the previously announced underwritten public offering of 3,833,334 shares of its common stock, offered at a price of $7.50 per share, which ...
Anthera Pharmaceuticals (ANTH) Looks Good: Stock Up 13%  Zacks.com
Anthera Pharmaceuticals Short Interest Up 46.8% in June (ANTH)  Dakota Financial News
Zacks Rating on Anthera Pharmaceuticals, Inc.
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) remains a strong buy in the latest set of rankings. The shares have received an average rating of 1 by 2 analysts.
Anthera Pharmaceuticals to Report 2015 Second Quarter and Operational Update ...  MarketWatch